Please try another search
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada.
Name | Age | Since | Title |
---|---|---|---|
Harold Morton Wolkin | 72 | 2024 | Independent Director |
Shantha Kodihalli | - | 2024 | Independent Director |
Robert Gabor | - | 2024 | Independent Director |
Michael D. Cochrane | - | 2024 | Independent Director |
Steven Theriault | - | 2024 | CEO, Chief Science Officer & Director |
Andrew Hurley | 55 | 2023 | Independent Director |
John Snisarenko | 61 | 2024 | Independent Director |
William W. Ollerhead | 58 | 2019 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review